Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

2(40.0%)

5Total

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05203523Not ApplicableCompleted

Investigational Dementia Treatment Study

Role: collaborator

NCT04789616Phase 2Recruiting

The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

Role: collaborator

NCT03448159Phase 2Completed

Fluoxetine Opens Window to Improve Motor Recovery After Stroke

Role: collaborator

NCT04054583Completed

Impact of Renovations in Long Term Care Living Spaces on Residents With Dementia, Their Families and Staff

Role: collaborator

NCT04138095Not ApplicableUnknown

Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care

Role: collaborator

NCT02123537Not ApplicableCompleted

Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation

Role: collaborator

All 6 trials loaded